|
US3766774A
(en)
|
1972-02-18 |
1973-10-23 |
H Clark |
Apparatus and method for measuring blood characteristics
|
|
US4270537A
(en)
*
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
USRE33405E
(en)
|
1979-12-28 |
1990-10-23 |
Research Corporation Technologies, Inc. |
Purified human prostate antigen
|
|
US4446122A
(en)
*
|
1979-12-28 |
1984-05-01 |
Research Corporation |
Purified human prostate antigen
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4818542A
(en)
|
1983-11-14 |
1989-04-04 |
The University Of Kentucky Research Foundation |
Porous microspheres for drug delivery and methods for making same
|
|
US4795436A
(en)
|
1983-11-14 |
1989-01-03 |
Bio-Mimetics, Inc. |
Bioadhesive composition and method of treatment therewith
|
|
US4638045A
(en)
*
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4596556A
(en)
*
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
GB8601100D0
(en)
|
1986-01-17 |
1986-02-19 |
Cosmas Damian Ltd |
Drug delivery system
|
|
US4806621A
(en)
*
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US4970299A
(en)
|
1986-07-03 |
1990-11-13 |
Sloan-Kettering Institute For Cancer Research |
Monoclonal antibodies selective for prostate cancer
|
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
US5736372A
(en)
*
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
CA1340581C
(en)
*
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
FR2608988B1
(fr)
*
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
|
GB8704027D0
(en)
*
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4903649A
(en)
|
1987-03-12 |
1990-02-27 |
Brunswick Corporation |
Fuel supply system with pneumatic amplifier
|
|
US4902615A
(en)
*
|
1987-03-27 |
1990-02-20 |
Biosciences Corporation Of Texas |
Detection of human cancer cells with antibodies to human cancer nucleolar antigen p120
|
|
DE3812289C2
(de)
|
1987-04-20 |
1995-06-08 |
Mitsubishi Electric Corp |
Leerlaufdrehzahlregelvorrichtung für eine Brennkraftmaschine
|
|
US4839416A
(en)
|
1987-06-09 |
1989-06-13 |
Ampad Corporation |
Low tack microsphere adhesive
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US5069936A
(en)
|
1987-06-25 |
1991-12-03 |
Yen Richard C K |
Manufacturing protein microspheres
|
|
US5019379A
(en)
*
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US5200181A
(en)
|
1988-01-11 |
1993-04-06 |
Massachusetts Institute Of Technology |
Oral bilirubin therapy
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
US5162504A
(en)
|
1988-06-03 |
1992-11-10 |
Cytogen Corporation |
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
|
|
JPH0249596A
(ja)
|
1988-08-09 |
1990-02-19 |
Masamichi Ueda |
ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体
|
|
US4959219A
(en)
|
1988-08-15 |
1990-09-25 |
Fisons Corporation |
Coating barriers comprising ethyl cellulose
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
EP0398903B1
(en)
|
1988-12-09 |
1992-06-17 |
Robert Bosch Gmbh |
Method for acceleration enrichment in fuel injection systems
|
|
US5334497A
(en)
|
1988-12-13 |
1994-08-02 |
Hideki Inaba |
Method of feeding a substrate into tubular bioreactor
|
|
US4976968A
(en)
|
1989-02-24 |
1990-12-11 |
Clinical Technologies Associates, Inc. |
Anhydrous delivery systems for pharmacological agents
|
|
US5010167A
(en)
*
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
WO1991006287A1
(en)
|
1989-11-06 |
1991-05-16 |
Enzytech, Inc. |
Protein microspheres and methods of using them
|
|
WO1991006286A1
(en)
|
1989-11-06 |
1991-05-16 |
Enzytech, Inc. |
Method for producing protein microspheres
|
|
US5312335A
(en)
*
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US6005087A
(en)
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
|
US6399754B1
(en)
*
|
1991-12-24 |
2002-06-04 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides
|
|
US5240963A
(en)
|
1990-01-19 |
1993-08-31 |
Nova Pharmaceutical Corporation |
Branched polyanhydrides
|
|
US6716580B2
(en)
*
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
|
US5789163A
(en)
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Enzyme linked oligonucleotide assays (ELONAS)
|
|
US6001577A
(en)
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
US5874218A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Method for detecting a target compound in a substance using a nucleic acid ligand
|
|
US5567588A
(en)
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
|
US5853984A
(en)
|
1990-06-11 |
1998-12-29 |
Nexstar Pharmaceuticals, Inc. |
Use of nucleic acid ligands in flow cytometry
|
|
EP0786469B1
(en)
|
1990-06-11 |
2006-03-01 |
Gilead Sciences, Inc. |
Methods of use of nucleic acid ligands
|
|
US5660985A
(en)
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
|
US5763177A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
US6280932B1
(en)
*
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
|
US6699474B1
(en)
|
1990-08-20 |
2004-03-02 |
Erich Hugo Cerny |
Vaccine and immunserum against drugs of abuse
|
|
US5190521A
(en)
*
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
*
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5175296A
(en)
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5403750A
(en)
|
1991-03-06 |
1995-04-04 |
W. R. Grace & Co.-Conn. |
Biocompatible, low protein adsorption affinity matrix
|
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
|
GB9118204D0
(en)
*
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
*
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US5383851A
(en)
*
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
KR940003548U
(ko)
|
1992-08-14 |
1994-02-21 |
김형술 |
세탁물 건조기
|
|
US6608201B2
(en)
|
1992-08-28 |
2003-08-19 |
3M Innovative Properties Company |
Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
US5399665A
(en)
*
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
EP0678034B1
(en)
|
1993-01-11 |
1999-05-26 |
Dana Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
|
US5512600A
(en)
*
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
*
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5820879A
(en)
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
DE59403734D1
(de)
*
|
1993-03-17 |
1997-09-18 |
Silica Gel Gmbh |
Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben
|
|
US5342781A
(en)
|
1993-07-15 |
1994-08-30 |
Su Wei Wen W |
External-loop perfusion air-lift bioreactor
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5744155A
(en)
|
1993-08-13 |
1998-04-28 |
Friedman; Doron |
Bioadhesive emulsion preparations for enhanced drug delivery
|
|
US6458539B1
(en)
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
|
US5798340A
(en)
*
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5500161A
(en)
*
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5596091A
(en)
*
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5716404A
(en)
*
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
US5599302A
(en)
*
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5786204A
(en)
|
1995-01-20 |
1998-07-28 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
|
US5686113A
(en)
|
1995-03-21 |
1997-11-11 |
Temple University Of The Commonwealth System Of Higher Education |
Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
|
|
US5876727A
(en)
|
1995-03-31 |
1999-03-02 |
Immulogic Pharmaceutical Corporation |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US20020150578A1
(en)
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
|
US5843732A
(en)
|
1995-06-06 |
1998-12-01 |
Nexstar Pharmaceuticals, Inc. |
Method and apparatus for determining consensus secondary structures for nucleic acid sequences
|
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
US5879712A
(en)
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
|
WO1997004747A1
(en)
|
1995-07-27 |
1997-02-13 |
Dunn James M |
Drug delivery systems for macromolecular drugs
|
|
US6096344A
(en)
|
1995-07-28 |
2000-08-01 |
Advanced Polymer Systems, Inc. |
Bioerodible porous compositions
|
|
US6395770B1
(en)
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
|
US5893397A
(en)
*
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
US5902599A
(en)
*
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US5898031A
(en)
*
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US20020106647A1
(en)
|
1996-07-24 |
2002-08-08 |
Segal Andrew H. |
Nucleic acid compositions and methods of introducing nucleic acids into cells
|
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
|
JP2001504448A
(ja)
|
1996-08-30 |
2001-04-03 |
フュルステ，イェンス，ペーター |
核酸の鏡面対称選択および進化
|
|
EP1006798A4
(en)
|
1996-09-05 |
2003-03-05 |
Massachusetts Inst Technology |
COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES
|
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
US6120666A
(en)
|
1996-09-26 |
2000-09-19 |
Ut-Battelle, Llc |
Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same
|
|
KR100518903B1
(ko)
|
1996-10-25 |
2005-10-06 |
미네소타 마이닝 앤드 매뉴팩춰링 캄파니 |
Ｔｈ2 매개 질병 및 관련 질병의 치료용 면역 반응 조절 화합물
|
|
US6995284B2
(en)
*
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US7205437B2
(en)
|
1996-11-27 |
2007-04-17 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
|
US7518013B2
(en)
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
|
US7759520B2
(en)
*
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US6127533A
(en)
|
1997-02-14 |
2000-10-03 |
Isis Pharmaceuticals, Inc. |
2'-O-aminooxy-modified oligonucleotides
|
|
WO1998051325A2
(en)
|
1997-05-15 |
1998-11-19 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
GB9713980D0
(en)
|
1997-07-03 |
1997-09-10 |
Danbiosyst Uk |
New conjugates
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
US6190913B1
(en)
|
1997-08-12 |
2001-02-20 |
Vijay Singh |
Method for culturing cells using wave-induced agitation
|
|
US7001996B1
(en)
|
1997-08-21 |
2006-02-21 |
The United States Of America As Represented By The Secretary Of The Army |
Enzymatic template polymerization
|
|
US6451527B1
(en)
|
1997-08-29 |
2002-09-17 |
Selective Genetics, Inc. |
Methods using genetic package display for selecting internalizing ligands for gene delivery
|
|
US20040136961A1
(en)
|
1997-10-09 |
2004-07-15 |
Ales Prokop |
Nanoparticulate composition for efficient gene transfer
|
|
DE19745950A1
(de)
|
1997-10-17 |
1999-04-22 |
Dds Drug Delivery Service Ges |
Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
|
|
AU734476B2
(en)
*
|
1997-11-05 |
2001-06-14 |
Baylor College Of Medicine |
Sequences for targeting metastatic cells
|
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
US6242246B1
(en)
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
|
US6506559B1
(en)
*
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
*
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
*
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
CA2329897A1
(en)
*
|
1998-04-28 |
1999-11-04 |
Galenica Pharmaceuticals, Inc. |
Polysaccharide-antigen conjugates
|
|
SE9801923D0
(sv)
|
1998-05-29 |
1998-05-29 |
Independent Pharmaceutical Ab |
Nicotine vaccine
|
|
DE19827164A1
(de)
*
|
1998-06-18 |
1999-12-23 |
Merck Patent Gmbh |
Katalytisch Titan(IV)-oxid vermittelte geminale symmetrische Dialkylierung von Carbonsäureamiden
|
|
US6265608B1
(en)
|
1998-06-30 |
2001-07-24 |
Eastman Chemical Company |
Method of purifying aromatic dicarboxylic acids
|
|
US6395718B1
(en)
|
1998-07-06 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
|
|
US6429200B1
(en)
|
1998-07-17 |
2002-08-06 |
Mirus Corporation |
Reverse micelles for delivery of nucleic acids
|
|
DE19839214C1
(de)
|
1998-08-28 |
2000-05-25 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Herstellung von sphärischen Mikropartikeln mit glatter Oberfläche, die ganz oder teilweise aus mindestens einem wasserunlöslichen linearen Polysaccharid bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und deren Verwendung
|
|
IL141868A0
(en)
|
1998-10-05 |
2002-03-10 |
M & E Biotech As |
Novel methods for therapeutic vaccination
|
|
EP1117444A2
(en)
|
1998-10-09 |
2001-07-25 |
The University Of Michigan |
Hydrogels and water soluble polymeric carriers for drug delivery
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6232082B1
(en)
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
TR200101943T2
(tr)
|
1999-01-08 |
2002-04-22 |
3M Innovative Properties Company |
Bir immun cevap modifayeri ile mukoza ile ilgili durumların tedavisine yönelik formülasyonlar ve metodlar.
|
|
US6403779B1
(en)
*
|
1999-01-08 |
2002-06-11 |
Isis Pharmaceuticals, Inc. |
Regioselective synthesis of 2′-O-modified nucleosides
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
US20030054360A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
EP1157270A1
(en)
|
1999-02-03 |
2001-11-28 |
Aclara BioSciences, Inc. |
Multichannel control in microfluidics
|
|
US6558951B1
(en)
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
|
US6110462A
(en)
|
1999-03-03 |
2000-08-29 |
The Scripps Research Institute |
Enzymatic DNA molecules that contain modified nucleotides
|
|
GB9905136D0
(en)
|
1999-03-06 |
1999-04-28 |
Danbiosyst Uk |
Surface modification of lamellar particles
|
|
US6943235B1
(en)
*
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
US20020102613A1
(en)
|
1999-05-18 |
2002-08-01 |
Hoogenboom Hendricus Renerus Jacobus Mattheus |
Novel Fab fragment libraries and methods for their use
|
|
WO2000077178A1
(en)
|
1999-06-16 |
2000-12-21 |
Boston Biomedical Research Institute |
IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
|
|
US6506887B1
(en)
*
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
|
WO2001012811A1
(en)
*
|
1999-08-12 |
2001-02-22 |
Urogenesys, Inc. |
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
|
|
US20020009466A1
(en)
*
|
1999-08-31 |
2002-01-24 |
David J. Brayden |
Oral vaccine compositions
|
|
US7429639B2
(en)
*
|
1999-09-29 |
2008-09-30 |
Ludwig Institute For Cancer Research |
SSX-2 peptides presented by HLA class II molecules
|
|
CA2321321A1
(en)
|
1999-09-30 |
2001-03-30 |
Isotis B.V. |
Polymers loaded with bioactive agents
|
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
WO2001047501A1
(en)
|
1999-12-29 |
2001-07-05 |
Nanodelivery, Inc. |
Drug delivery system exhibiting permeability control
|
|
AU774593C
(en)
|
2000-01-13 |
2005-06-23 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
US20050020525A1
(en)
*
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20050032733A1
(en)
*
|
2001-05-18 |
2005-02-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
|
|
US8202979B2
(en)
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
|
US7534417B2
(en)
|
2000-02-24 |
2009-05-19 |
Agensys, Inc. |
103P2D6: tissue specific protein highly expressed in various cancers
|
|
SE0000933D0
(sv)
|
2000-03-21 |
2000-03-21 |
Independent Pharmaceutica Ab |
Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
|
|
PT1309726E
(pt)
*
|
2000-03-30 |
2010-03-08 |
Whitehead Biomedical Inst |
Mediadores de interferência por rna específicos de sequência de rna
|
|
US7217770B2
(en)
|
2000-05-17 |
2007-05-15 |
Samyang Corporation |
Stable polymeric micelle-type drug composition and method for the preparation thereof
|
|
US6610713B2
(en)
|
2000-05-23 |
2003-08-26 |
North Shore - Long Island Jewish Research Institute |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
|
US20020151004A1
(en)
|
2000-07-24 |
2002-10-17 |
Roger Craig |
Delivery vehicles and methods for using the same
|
|
US20040260108A1
(en)
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
|
US6998500B2
(en)
*
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
US7253210B2
(en)
|
2002-10-15 |
2007-08-07 |
University Of Tennessee Research Foundation |
Methylene-bridged selective androgen receptor modulators and methods of use thereof
|
|
US20020173495A1
(en)
|
2000-08-24 |
2002-11-21 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
EP1401801B1
(en)
*
|
2000-08-24 |
2006-11-02 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
|
IL154425A0
(en)
|
2000-08-24 |
2003-09-17 |
Univ Tennessee Res H Corp |
Selective androgen receptor modulators and methods of use thereof
|
|
US6838484B2
(en)
*
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
|
US7026500B2
(en)
*
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
|
US20030232792A1
(en)
|
2000-08-24 |
2003-12-18 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
US6503538B1
(en)
|
2000-08-30 |
2003-01-07 |
Cornell Research Foundation, Inc. |
Elastomeric functional biodegradable copolyester amides and copolyester urethanes
|
|
US6376190B1
(en)
*
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
|
US20040067196A1
(en)
|
2000-10-11 |
2004-04-08 |
Brunke Karen J. |
Targeted therapeutic lipid constructs
|
|
US6589562B1
(en)
|
2000-10-25 |
2003-07-08 |
Salvona L.L.C. |
Multicomponent biodegradable bioadhesive controlled release system for oral care products
|
|
US20040259247A1
(en)
|
2000-12-01 |
2004-12-23 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
|
TWI246524B
(en)
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
|
WO2002098885A1
(en)
|
2001-02-07 |
2002-12-12 |
Beth Israel Deaconess Medical Center |
Modified psma ligands and uses related thereto
|
|
US7097837B2
(en)
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US7326564B2
(en)
|
2001-02-20 |
2008-02-05 |
St. Jude Medical, Inc. |
Flow system for medical device evaluation and production
|
|
ATE286430T1
(de)
|
2001-03-22 |
2005-01-15 |
Cognis Iberia Sl |
Nanokapseln
|
|
WO2002076469A1
(en)
|
2001-03-27 |
2002-10-03 |
Baylor College Of Medicine |
A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
WO2004030608A2
(en)
|
2001-06-05 |
2004-04-15 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
DE60140863D1
(de)
|
2001-06-10 |
2010-02-04 |
Noxxon Pharma Ag |
Verwendung von L-Polynukleotiden zur diagnostischen Bilderzeugung
|
|
US20030022868A1
(en)
*
|
2001-06-25 |
2003-01-30 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
AU2775402A
(en)
*
|
2001-06-29 |
2003-01-02 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
|
JP4088251B2
(ja)
|
2001-07-02 |
2008-05-21 |
オリエンタル酵母工業株式会社 |
ニコチンアミドアデニンジヌクレオチドリン酸（ｎａｄｐ）の製造方法
|
|
BR0103887C1
(pt)
|
2001-07-17 |
2005-11-08 |
Univ Minas Gerais |
Composições imunogênicas contendo microesferas biodegradáveis encapsulando antìgenos, vetores gênicos e adjuvantes
|
|
EP1279404A1
(en)
|
2001-07-26 |
2003-01-29 |
Istituto Superiore di Sanità |
Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
|
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
|
US7579163B2
(en)
|
2001-08-16 |
2009-08-25 |
Statoil Asa |
Method of fermentation
|
|
US20060004042A1
(en)
*
|
2001-08-23 |
2006-01-05 |
Dalton James T |
Formulations comprising selective androgen receptor modulators
|
|
US6818732B2
(en)
|
2001-08-30 |
2004-11-16 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
WO2003028657A2
(en)
|
2001-10-03 |
2003-04-10 |
The Johns Hopkins University |
Compositions for oral gene therapy and methods of using same
|
|
US20030134810A1
(en)
|
2001-10-09 |
2003-07-17 |
Chris Springate |
Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
|
|
BRPI0213226B1
(pt)
|
2001-10-10 |
2016-03-01 |
Pf Medicament |
processo de preparação de uma composição farmacêutica sob forma de microesferas com liberação prolongada de um princípio ativo hidrossolúvel, e, microesferas
|
|
US7879317B2
(en)
|
2001-10-18 |
2011-02-01 |
Samyang Corporation |
Polymeric micelle compositions with improved stability and methods of making thereof
|
|
JP4425536B2
(ja)
|
2001-10-30 |
2010-03-03 |
株式会社吉野工業所 |
容器とその熱成形装置および熱成形方法
|
|
AU2002363998A1
(en)
|
2001-12-15 |
2003-06-30 |
Spherics, Inc. |
Bioadhesive drug delivery system with enhanced gastric retention
|
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
|
WO2003057670A2
(en)
*
|
2001-12-28 |
2003-07-17 |
Guilford Pharmaceuticals Inc. |
Indoles as naaladase inhibitors
|
|
AU2003205077A1
(en)
|
2002-01-10 |
2003-07-30 |
Johns Hopkins University |
Imaging agents and methods of imaging naaladase of psma
|
|
US6720008B2
(en)
|
2002-01-22 |
2004-04-13 |
Pr Pharmaceuticals, Inc. |
Composition and method for the encapsulation of water-soluble molecules into nanoparticles
|
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
EP1476492A1
(en)
|
2002-02-22 |
2004-11-17 |
Insert Therapeutics Inc. |
Carbohydrate-modified polymers, compositions and uses related thereto
|
|
US20030232013A1
(en)
|
2002-02-22 |
2003-12-18 |
Gary Sieckman |
Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
|
|
EP1487458B1
(en)
|
2002-02-28 |
2011-11-16 |
University Of Tennessee Research Foundation |
Multi-substituted selective androgen receptor modulators and methods of use thereof
|
|
US7803970B2
(en)
*
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
|
US7344700B2
(en)
*
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
CA2476657A1
(en)
|
2002-02-28 |
2003-09-12 |
The University Of Tennessee Research Corporation |
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
US20060165987A1
(en)
|
2002-04-05 |
2006-07-27 |
Patrice Hildgen |
Stealthy polymeric biodegradable nanospheres and uses thereof
|
|
US7285289B2
(en)
*
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
US7524630B2
(en)
*
|
2002-04-22 |
2009-04-28 |
University Of Florida Research Foundation, Inc. |
Functionalized nanoparticles and methods of use
|
|
JP2003342168A
(ja)
|
2002-05-24 |
2003-12-03 |
Nano Career Kk |
注射用薬物含有ポリマーミセル製剤の製造方法
|
|
US6819165B2
(en)
|
2002-05-30 |
2004-11-16 |
Analog Devices, Inc. |
Voltage regulator with dynamically boosted bias current
|
|
MXPA04012567A
(es)
|
2002-06-11 |
2005-04-19 |
Ethypharm Sa |
Nanocapsulas lipidicas encubiertas, metodos para la preparacion de las mismas y uso de las mismas como un portador para principios activos.
|
|
US7741371B2
(en)
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
GEP20074191B
(en)
*
|
2002-06-17 |
2007-09-10 |
Univ Tennessee Res Foundation |
N-bridged selective androgen receptor modulators and methods of use thereof
|
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
AU2003276131A1
(en)
*
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
JP2005533794A
(ja)
|
2002-06-18 |
2005-11-10 |
アーケミックス コーポレイション |
アプタマー−毒素分子およびこれを使用する方法
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
NZ538812A
(en)
|
2002-08-15 |
2009-02-28 |
3M Innovative Properties Co |
Immunostimulatory compositions and methods of stimulating an immune response
|
|
US6875605B1
(en)
|
2002-08-21 |
2005-04-05 |
Florida State University Research Foundation, Inc. |
Modular cell culture bioreactor and associated methods
|
|
US7488792B2
(en)
*
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
|
AU2003267583A1
(en)
|
2002-09-19 |
2004-04-08 |
The Chancellor, Master And Scholars Of The University Of Oxford |
Molecular arrays and single molecule detection
|
|
US7008411B1
(en)
*
|
2002-09-30 |
2006-03-07 |
Advanced Cardiovascular Systems, Inc. |
Method and apparatus for treating vulnerable plaque
|
|
US20040087810A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
|
AU2003300184B8
(en)
|
2002-12-30 |
2009-12-03 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
|
EP2457892A1
(en)
|
2003-01-13 |
2012-05-30 |
University of Tennessee Research Foundation |
Large-scale synthesis of selective androgen receptor modulators
|
|
US20040156846A1
(en)
|
2003-02-06 |
2004-08-12 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles using L6 antibodies
|
|
JP2006517974A
(ja)
|
2003-02-13 |
2006-08-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｉｒｍ化合物およびトル様受容体８に関する方法および組成物
|
|
WO2004071493A1
(en)
|
2003-02-17 |
2004-08-26 |
Peter Burkhard |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
US20040167103A1
(en)
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
WO2004096140A2
(en)
|
2003-04-25 |
2004-11-11 |
The Penn State Research Foundation |
Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
|
|
US20050008572A1
(en)
|
2003-04-29 |
2005-01-13 |
Ales Prokop |
Nanoparticular tumor targeting and therapy
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
US20040266688A1
(en)
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
|
GB0312309D0
(en)
|
2003-05-29 |
2003-07-02 |
Gaslini Children S Hospital G |
Targeted liposome
|
|
US20060239907A1
(en)
|
2003-06-03 |
2006-10-26 |
The Trustees Of The University Of Pennsylvania |
Stealthy nano agents
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
US7149574B2
(en)
|
2003-06-09 |
2006-12-12 |
Palo Alto Investors |
Treatment of conditions through electrical modulation of the autonomic nervous system
|
|
DE602004028468D1
(de)
|
2003-06-17 |
2010-09-16 |
Mannkind Corp |
Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
|
|
AU2004260935A1
(en)
|
2003-06-30 |
2005-02-10 |
Canji, Inc. |
Polymer encapsulation of adenoviruses
|
|
US20050256071A1
(en)
|
2003-07-15 |
2005-11-17 |
California Institute Of Technology |
Inhibitor nucleic acids
|
|
ES2559828T3
(es)
|
2003-07-16 |
2016-02-16 |
Protiva Biotherapeutics Inc. |
ARN de interferencia encapsulado en lípidos
|
|
US7362068B2
(en)
*
|
2003-07-23 |
2008-04-22 |
Asmo Co., Ltd. |
Closing member control system
|
|
JP4533382B2
(ja)
|
2003-08-28 |
2010-09-01 |
セルラ・インコーポレイテッド |
マイクロ流体分析およびソーティング用の一体化された構造物
|
|
CN1875101A
(zh)
|
2003-09-02 |
2006-12-06 |
北卡罗来纳-查佩尔山大学 |
生物可降解聚合物－配体偶联物及其在细胞亚群的分离和细胞的低温保藏、培养和移植中的应用
|
|
AU2004281634B2
(en)
|
2003-09-03 |
2011-01-27 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
|
ES2629696T3
(es)
|
2003-09-17 |
2017-08-14 |
Nektar Therapeutics |
Profármacos poliméricos multibrazo
|
|
US7829119B2
(en)
|
2003-10-20 |
2010-11-09 |
William Marsh Rice University |
Method to fabricate microcapsules from polymers and charged nanoparticles
|
|
US8129506B2
(en)
|
2003-10-24 |
2012-03-06 |
Genzyme Corporation |
Modulation of the interaction of MUC1 with MUC1 ligands
|
|
TW200527013A
(en)
|
2003-10-28 |
2005-08-16 |
Arryx Inc |
System and method for manipulating and processing materials using holographic optical trapping
|
|
WO2005055949A2
(en)
|
2003-12-09 |
2005-06-23 |
The Children's Hospital Of Philadelphia |
Sustained release preparations composed of biocompatible complex microparticles
|
|
DK1704585T3
(en)
*
|
2003-12-19 |
2017-05-22 |
Univ North Carolina Chapel Hill |
Methods for preparing isolated micro- and nanostructures using soft lithography or printing lithography
|
|
US7846412B2
(en)
|
2003-12-22 |
2010-12-07 |
Emory University |
Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
|
|
US7335744B2
(en)
|
2003-12-23 |
2008-02-26 |
The Regents Of The California University |
Prostate cancer specific internalizing human antibodies
|
|
WO2005065418A2
(en)
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
EP1713514B1
(en)
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
US20070053845A1
(en)
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
WO2005084639A2
(en)
|
2004-03-03 |
2005-09-15 |
Spherics, Inc. |
Polymeric drug delivery system for hydrophobic drugs
|
|
WO2005110438A2
(en)
|
2004-04-15 |
2005-11-24 |
Massachusetts Institute Of Technology |
Methods and products related to the intracellular delivery of polysaccharides
|
|
AU2005325262B2
(en)
|
2004-04-27 |
2011-08-11 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
|
ES2246695B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
|
|
WO2005112885A2
(en)
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
|
US8821859B2
(en)
|
2004-05-19 |
2014-09-02 |
Agency For Science, Technology And Research |
Methods and articles for the delivery of therapeutic agents
|
|
CN100475837C
(zh)
|
2004-06-11 |
2009-04-08 |
北京键凯科技有限公司 |
多叉分支的聚乙二醇-氨基酸寡肽及其活性衍生物和药物结合物
|
|
US20080124400A1
(en)
|
2004-06-24 |
2008-05-29 |
Angiotech International Ag |
Microparticles With High Loadings Of A Bioactive Agent
|
|
JP2008512350A
(ja)
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
US20060258628A1
(en)
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
|
CN101027100A
(zh)
|
2004-07-22 |
2007-08-29 |
健泰科生物技术公司 |
治疗干燥综合征的方法
|
|
KR100604976B1
(ko)
|
2004-09-03 |
2006-07-28 |
학교법인연세대학교 |
다작용기 리간드로 안정화된 수용성 나노입자
|
|
EP1791943A1
(en)
|
2004-09-22 |
2007-06-06 |
CatchMabs B.V. |
Bioreactor assembly comprising at least one tray-like rocking platform
|
|
US9079765B2
(en)
|
2004-10-01 |
2015-07-14 |
Midatech Ltd. |
Nanoparticles comprising antigens and adjuvants, and immunogenic structures
|
|
AU2005294214A1
(en)
|
2004-10-07 |
2006-04-20 |
Emory University |
Multifunctional nanoparticles conjugates and their use
|
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
DK1817340T3
(da)
|
2004-11-12 |
2012-08-13 |
Xencor Inc |
Fc-varianter med ændret binding til fcrn
|
|
US20060111271A1
(en)
|
2004-11-24 |
2006-05-25 |
Cerny Erich H |
Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements
|
|
WO2006066158A2
(en)
|
2004-12-14 |
2006-06-22 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of mll-af4 and uses thereof
|
|
WO2006090924A1
(ja)
|
2005-02-28 |
2006-08-31 |
The University Of Tokyo |
ペプチドリガンドを有するブロック共重合体
|
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
|
WO2006096754A2
(en)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to psma and their use as prostate cancer therapeutics
|
|
WO2006099445A2
(en)
|
2005-03-14 |
2006-09-21 |
Massachusetts Institute Of Technology |
Nanocells for diagnosis and treatment of diseases and disorders
|
|
EP1872793B1
(en)
|
2005-04-20 |
2012-10-10 |
Mitsuru Akashi |
Polyamino acid for use as adjuvant
|
|
EP1877069A2
(de)
|
2005-05-04 |
2008-01-16 |
Noxxon Pharma AG |
Neue verwendung von spiegelmeren
|
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
|
WO2006133271A2
(en)
|
2005-06-06 |
2006-12-14 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
EP1898955A2
(en)
|
2005-06-17 |
2008-03-19 |
Nektar Therapeutics AL, Corporation |
Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs
|
|
KR20080031379A
(ko)
|
2005-07-11 |
2008-04-08 |
와이어쓰 |
글루타메이트 아그레카나제 저해제
|
|
CA2619533C
(en)
|
2005-08-17 |
2014-02-04 |
Bioneer Corporation |
Sirna-hydrophilic polymer conjugates for intracellular delivery of sirna and method thereof
|
|
EP1932538A4
(en)
|
2005-08-25 |
2009-10-21 |
Taiho Pharmaceutical Co Ltd |
BIODEGRADABLE NANOTEHICLES WITH IMMOBILIZED OR CAPACITATED T-CELL-RECOGNIZABLE EPITOPEPEPID
|
|
AU2006293410B2
(en)
|
2005-09-20 |
2012-10-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Nanoparticles for targeted delivery of active agents
|
|
EP1973608A1
(en)
|
2005-12-14 |
2008-10-01 |
Cytos Biotechnology AG |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
KR101529318B1
(ko)
|
2005-12-19 |
2015-06-16 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
US20070233534A1
(en)
|
2006-01-06 |
2007-10-04 |
Marware Inc. |
Project management system and method
|
|
US20070231392A1
(en)
|
2006-01-23 |
2007-10-04 |
Ernst Wagner |
CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
WO2007109364A2
(en)
|
2006-03-20 |
2007-09-27 |
The General Hospital Corporation |
Intramolecularly quenched fluorochrome conjugates and methods of use
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
|
CA2648243C
(en)
|
2006-04-11 |
2015-12-22 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
|
US20100247653A1
(en)
|
2006-04-11 |
2010-09-30 |
Hans Lautenschlager |
Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
|
|
US8367113B2
(en)
*
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
CN101467235A
(zh)
|
2006-06-13 |
2009-06-24 |
Nxp股份有限公司 |
双栅极晶体管及其制造方法
|
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20090117549A1
(en)
*
|
2006-07-18 |
2009-05-07 |
Weihong Tan |
Aptamer-based methods for identifying cellular biomarkers
|
|
US20100144845A1
(en)
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
US20080171059A1
(en)
|
2006-08-07 |
2008-07-17 |
Shanshan Wu Howland |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
US9248121B2
(en)
|
2006-08-21 |
2016-02-02 |
Abbott Laboratories |
Medical devices for controlled drug release
|
|
US20080078921A1
(en)
|
2006-08-25 |
2008-04-03 |
Motorola, Inc. |
Multiple light sensors and algorithms for luminance control of mobile display devices
|
|
WO2008041703A1
(en)
|
2006-10-02 |
2008-04-10 |
Osaka University |
Adjuvant for influenza vaccine and influenza vaccine
|
|
ES2847275T3
(es)
|
2006-11-08 |
2021-08-02 |
Molecular Insight Pharm Inc |
Heterodímeros de ácido glutámico
|
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
EP2099496A2
(en)
|
2006-12-08 |
2009-09-16 |
Massachusetts Institute of Technology |
Delivery of nanoparticles and/or agents to cells
|
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
EP2136788B1
(en)
|
2007-03-30 |
2011-10-26 |
Bind Biosciences, Inc. |
Cancer cell targeting using nanoparticles
|
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
|
US20080311045A1
(en)
|
2007-06-06 |
2008-12-18 |
Biovaluation & Analysis, Inc. |
Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
|
|
EP2630966B1
(en)
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
RU2540871C2
(ru)
|
2008-02-01 |
2015-02-10 |
Альфа-О Пептидес Аг |
Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
|
|
EP2106806A1
(en)
|
2008-03-31 |
2009-10-07 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Nanoparticles for targeted delivery of active agents to the lung
|
|
ES2721850T3
(es)
|
2008-06-16 |
2019-08-05 |
Pfizer |
Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas
|
|
JP2012501965A
(ja)
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法
|
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8591905B2
(en)
*
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
WO2010068866A2
(en)
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
US20100216804A1
(en)
|
2008-12-15 |
2010-08-26 |
Zale Stephen E |
Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
|
|
WO2010114770A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
WO2010114768A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
|
JP2014526604A
(ja)
|
2011-09-20 |
2014-10-06 |
ザ プロクター アンド ギャンブル カンパニー |
イソプレノイド由来界面活性剤を含む持続可能な界面活性剤系を含む洗剤組成物
|